Ladenburg Thalmann Financial Services’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $4.93M | Hold |
1,774,915
| – | – | 0.03% | 488 |
|
|
2019
Q3 | $2.71M | Hold |
1,774,915
| – | – | 0.02% | 695 |
|
|
2019
Q2 | $3.69M | Buy |
1,774,915
+9,500
| +0.5% | +$19.8K | 0.03% | 553 |
|
|
2019
Q1 | $6.32M | Hold |
1,765,415
| – | – | 0.05% | 373 |
|
|
2018
Q4 | $6.76M | Hold |
1,765,415
| – | – | 0.06% | 287 |
|
|
2018
Q3 | $17.1M | Buy |
1,765,415
+100
| +0% | +$966 | 0.14% | 149 |
|
|
2018
Q2 | $8.83M | Hold |
1,765,315
| – | – | 0.08% | 230 |
|
|
2018
Q1 | $8.83M | Hold |
1,765,315
| – | – | 0.08% | 230 |
|
|
2017
Q4 | $8.92M | Sell |
1,765,315
-3,576
| -0.2% | -$18.1K | 0.09% | 222 |
|
|
2017
Q3 | $13.3M | Sell |
1,768,891
-3,526,054
| -67% | -$26.6M | 0.14% | 147 |
|
|
2017
Q2 | $19.1M | Hold |
5,294,945
| – | – | 0.22% | 105 |
|
|
2017
Q1 | $17.2M | Hold |
5,294,945
| – | – | 0.22% | 104 |
|
|
2016
Q4 | $13M | Buy |
5,294,945
+5,294,445
| +1,058,889% | +$13M | 0.18% | 123 |
|
|
2016
Q3 | $2K | Buy |
+500
| New | +$2K | ﹤0.01% | 4437 |
|
|
2015
Q3 | – | Sell |
-300
| Closed | -$4K | – | 4589 |
|
|
2015
Q2 | $4K | Hold |
300
| – | – | ﹤0.01% | 4108 |
|
|
2015
Q1 | $5K | Buy |
+300
| New | +$5K | ﹤0.01% | 3948 |
|